Elleste Duet Conti is a continuous combined hormone replacement therapy (HRT) for postmenopausal women who have a uterus. It is used to manage symptoms associated with oestrogen deficiency following menopause, such as hot flushes, night sweats, mood changes, and vaginal dryness. The treatment also supports bone health and may be used to help prevent osteoporosis when other options are not suitable.
How It Works
Each Elleste Duet Conti tablet contains a fixed combination of estradiol, a synthetic form of the body’s natural oestrogen, and norethisterone, a synthetic progestogen. The oestrogen component replaces the hormone levels that decline after menopause, providing relief from vasomotor and genitourinary symptoms. The progestogen component is included to protect the endometrium (lining of the womb) from the risks associated with unopposed oestrogen, such as endometrial hyperplasia or cancer. Continuous daily dosing avoids monthly withdrawal bleeds, making it ideal for women who prefer a no-bleed HRT regimen.
Why Choose Elleste Duet Conti
Elleste Duet Conti offers effective symptom control in a single daily tablet, combining both oestrogen and progestogen. It is especially suitable for postmenopausal women who prefer not to have a monthly bleed. With its continuous formulation, it offers convenience and simplicity, while maintaining endometrial protection. Available in a fixed-dose strength, it is a well-established treatment with a proven safety profile when used appropriately.
Important Note
Elleste Duet Conti is not a contraceptive and is intended only for postmenopausal women. It should not be used by women with a history of hormone-sensitive cancers, thromboembolic disease, or liver impairment. Treatment must begin only after a comprehensive medical evaluation, and regular monitoring is recommended. Any unusual vaginal bleeding, changes in breast tissue, or persistent side effects should be reported to a healthcare provider promptly.
